Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glu
ST000380 · Metabolomics Workbench
TL;DR — A 226.9 KB metabolomics / lipidomics deposit (ST000380, 3 file(s), liver) in the MASLD / NAFLD / NASH data lake. under-mined portal (Metabolomics Workbench); modality=metabolomics.
0. Summary
Biological premise.
The following premise is sourced from the repository record (not fabricated).
High fructose consumption has been implicated with deleterious effects on human health, including hyperlipidemia elicited through de novo lipogenesis. However, more global effects of fructose on cellular metabolism have not been elucidated. In order to explore the metabolic impact of fructose-containing nutrients, we applied both GC-TOF and HILIC-QTOF mass spectrometry metabolomic strategies using extracts from cultured HepG2 cells exposed to fructose, glucose, or fructose + glucose. Cellular responses were analyzed in a time-dependent manner, incubated in media containing 5.5 mM glucose + 5.0 mM fructose in comparison to controls incubated in media containing either 5.5 mM glucose or 10.5 mM glucose. Mass spectrometry identified 156 unique known metabolites and a large number of unknown compounds, which revealed metabolite changes due to both utilization of fructose and high-carbohydrate loads independent of hexose structure. Fructose was shown to be partially converted to sorbitol, and generated higher levels of fructose-1-phosphate as a precursor for glycolytic intermediates. Differentially regulated ratios of 3-phosphoglycerate to serine pathway intermediates in high fructose media indicated a diversion of carbon backbones away from energy metabolism. Additionally, high fructoseconditions changed levels of complex lipids toward phosphatidylethanolamines. Patterns of acylcarnitines in response to high hexose exposure (10.5 mM glucose or glucose/fructose combination) suggested a reduction in mitochondrial beta-oxidation.
High fructose consumption has been implicated with deleterious effects on human health, including hyperlipidemia elicited through de novo lipogenesis. However, more global effects of fructose on cellular metabolism have not been elucidated. In order to explore the metabolic impact of fructose-containing nutrients, we applied both GC-TOF and HILIC-QTOF mass spectrometry metabolomic strategies using extracts from cultured HepG2 cells exposed to fructose, glucose, or fructose + glucose. Cellular responses were analyzed in a time-dependent manner, incubated in media containing 5.5 mM glucose + 5.0 mM fructose in comparison to controls incubated in media containing either 5.5 mM glucose or 10.5 mM glucose. Mass spectrometry identified 156 unique known metabolites and a large number of unknown compounds, which revealed metabolite changes due to both utilization of fructose and high-carbohydrate loads independent of hexose structure. Fructose was shown to be partially converted to sorbitol, and generated higher levels of fructose-1-phosphate as a precursor for glycolytic intermediates. Differentially regulated ratios of 3-phosphoglycerate to serine pathway intermediates in high fructose media indicated a diversion of carbon backbones away from energy metabolism. Additionally, high fructoseconditions changed levels of complex lipids toward phosphatidylethanolamines. Patterns of acylcarnitines in response to high hexose exposure (10.5 mM glucose or glucose/fructose combination) suggested a reduction in mitochondrial beta-oxidation.
Every file in this dataset is a metabolomics / lipidomics readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from Metabolomics Workbench.
Assay and processing.
Modality: metabolomics / lipidomics (repository subtype: metabolomics). Tier-1 (must-have) for this modality = feature × sample intensity matrix (MAF/data table) + sample factors; Tier-2 (recommended) = feature annotation (m/z, RT, HMDB/KEGG ids), author DE/pathway tables, QC pools; Tier-3 (optional / raw) = raw spectra (.mzML/.cdf/vendor), peak-picking parameters. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.
Sources.
- ST000380 — Metabolomics Workbench deposit (under-mined portal (Metabolomics Workbench); modality=metabolomics).
- PMIDs: none recorded in the index for this deposit.
| Disease | MASLD / NAFLD / NASH |
| Assay / modality | metabolomics / lipidomics — metabolomics |
| Organisms | unspecified |
| Repository | Metabolomics Workbench — NIH Metabolomics Workbench |
| Accession | ST000380 |
| Access | Public (open); files mirrored in this dataset's input/ folder. |
| Number of studies | 1 |
| Number of files | 3 |
| Total size | 226,900 bytes (≈ 226.9 KB) |
1. Datasets — sample sources, protocols, experiment design and metadata
Landed sources at a glance.
| Source | Access | Files |
|---|---|---|
| Metabolomics Workbench | public / OPEN-processed | 3 |
The deposit at a glance.
| Accession | Description | Organism | Samples | Scale |
|---|---|---|---|---|
| ST000380 | under-mined portal (Metabolomics Workbench); modality=metabolomics | unspecified | n/a | 3 files · 226.9 KB |
ST000380 — Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glu
Metabolomics Workbench record · 3 files · 226.9 KB
-
Sample source. unspecified material; MASLD/NAFLD/NASH context (under-mined portal (Metabolomics Workbench); modality=metabolomics).
-
Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.
-
Experiment design. Repository subtype: metabolomics; disease context MASLD/NAFLD/NASH.
-
Metadata available. See the annotated file table below; per-sample metadata ships in the ISA-Tab / SDRF / metadata file(s) where present.
-
Files (annotated).
File What it is ST000380_mwtab.txtMetabolomics Workbench mwTab — study design, sample factors, and named-metabolite × sample data table (372 data rows × 1 cols) ST000380_data.txtNamed-metabolite × sample data table (feature intensities) (4,535 data rows × 2 cols) ST000380_named_metabolites.txtNamed-metabolite reference list (identified features) (9 data rows × 2 cols) -
How this experiment became a dataset. ST000380 resolved via the Metabolomics Workbench record API → 3 open file(s) fetched into this dataset's
input/folder → sizes verified on disk (226,900 bytes (≈ 226.9 KB)). -
Completeness (metabolomics / lipidomics). Present: feature/intensity table (Tier-1); metabolite annotation (Tier-2). Not detected among landed files: sample factors (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)
2. Analyses this atlas supports
- Differential-abundance / pathway analysis. Start from
ST000380_data.txt(feature × sample intensities) to run group contrasts and metabolite-set enrichment. - Cross-cohort MASLD integration. Combine this deposit (ST000380) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.
Reproduce. All files are in this dataset's input/ folder; the source of record is ST000380 (https://www.metabolomicsworkbench.org/rest/study/study_id/ST000380/mwtab/txt). Re-fetch with the MASLD crawler (masld_download_pass.py --only ST000380); sizes are verified on disk and recorded in this dataset's metadata.json.
Citation
Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glu. Metabolomics Workbench accession ST000380. https://www.metabolomicsworkbench.org/rest/study/study_id/ST000380/mwtab/txt
About this dataset
This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.
Analyze it in Drylab
Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:
- Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
- Normalize, select variable genes, then cluster the cells and draw a UMAP.
- Annotate clusters with marker genes and compare the cell-type mix between conditions.
- Run differential expression between cell types or samples to characterize masld/nafld/nash biology.